These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 17712228)
1. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression. Wang R; Lin F; Wang X; Gao P; Dong K; Wei SH; Cheng SY; Zhang HZ Cancer Biol Ther; 2007 Aug; 6(8):1295-301. PubMed ID: 17712228 [TBL] [Abstract][Full Text] [Related]
2. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells. Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350 [TBL] [Abstract][Full Text] [Related]
3. [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy]. Zhang Y; Ma H; Liu SL; Liu YX; Zheng DX Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):475-9. PubMed ID: 18642790 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo. Shi YA; Zhao Q; Zhang LH; Du W; Wang XY; He X; Wu S; Li YL Int J Oncol; 2014 Sep; 45(3):1216-24. PubMed ID: 24920549 [TBL] [Abstract][Full Text] [Related]
5. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells. Zhang HZ; Wang Y; Gao P; Lin F; Liu L; Yu B; Ren JH; Zhao H; Wang R Cancer Biol Ther; 2006 Nov; 5(11):1457-61. PubMed ID: 17012855 [TBL] [Abstract][Full Text] [Related]
6. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823 [TBL] [Abstract][Full Text] [Related]
7. [Influence of survivin gene repression by RNA interference on the radiosensitivity and chemosensitivity to cisplatin of cervical cancer cell HeLa]. Song H; Xin XY; Xiao F; Wang DT; Han X; Guo HL Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):554-8. PubMed ID: 17083843 [TBL] [Abstract][Full Text] [Related]
8. RNAi gene therapy of SiHa cells via targeting human TERT induces growth inhibition and enhances radiosensitivity. Zhang W; Xing L Int J Oncol; 2013 Oct; 43(4):1228-34. PubMed ID: 23921425 [TBL] [Abstract][Full Text] [Related]
9. Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers. Li QX; Zhao J; Liu JY; Jia LT; Huang HY; Xu YM; Zhang Y; Zhang R; Wang CJ; Yao LB; Chen SY; Yang AG Cancer Biol Ther; 2006 Jul; 5(7):860-6. PubMed ID: 16861916 [TBL] [Abstract][Full Text] [Related]
10. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA. Kurvinen K; Syrjänen S; Johansson B Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210 [TBL] [Abstract][Full Text] [Related]
11. Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma. Li Y; Li M; Yao G; Geng N; Xie Y; Feng Y; Zhang P; Kong X; Xue J; Cheng S; Zhou J; Xiao L Cancer Gene Ther; 2011 May; 18(5):318-25. PubMed ID: 21233858 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation and induction of apoptosis in human renal carcinoma cells by anti-telomerase small interfering RNAs. Zheng JN; Sun YF; Pei DS; Liu JJ; Chen JC; Li W; Sun XQ; Shi QD; Han RF; Ma TX Acta Biochim Biophys Sin (Shanghai); 2006 Jul; 38(7):500-6. PubMed ID: 16820866 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity. Guan HT; Xue XH; Dai ZJ; Wang XJ; Li A; Qin ZY World J Gastroenterol; 2006 May; 12(18):2901-7. PubMed ID: 16718816 [TBL] [Abstract][Full Text] [Related]
14. Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter. Zhang M; Shi S; Guo R; Miao Y; Li B Oncol Rep; 2016 Oct; 36(4):2289-97. PubMed ID: 27573304 [TBL] [Abstract][Full Text] [Related]
15. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Endoh T; Tsuji N; Asanuma K; Yagihashi A; Watanabe N Exp Cell Res; 2005 May; 305(2):300-11. PubMed ID: 15817155 [TBL] [Abstract][Full Text] [Related]
16. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo. Yang W; Sun T; Cao J; Liu F Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells. Fang L; Cheng Q; Li W; Liu J; Li L; Xu K; Zheng J Virus Res; 2014 Mar; 181():61-71. PubMed ID: 24463503 [TBL] [Abstract][Full Text] [Related]
18. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218 [TBL] [Abstract][Full Text] [Related]
19. [Study on apoptosis of human cervical carcinoma HeLa cells with RNA interference targeting hTERT]. Zhao Y; Ren JL; Zhang R; Ma LY; Bao W; Wang CJ; Yang AG Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):524-6. PubMed ID: 15989808 [TBL] [Abstract][Full Text] [Related]
20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]